CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
51.76
+2.06 (4.14%)
At close: Apr 8, 2026, 4:00 PM EDT
51.36
-0.40 (-0.77%)
After-hours: Apr 8, 2026, 7:56 PM EDT
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $4.97 billion as of April 8, 2026. Its market cap has increased by 40.52% in one year.
Market Cap
4.97B
Enterprise Value
3.20B
1-Year Change
40.52%
Ranking
Category
Stock Price
$51.76
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $4.97B, an increase of 787.02%. That is a compound annual growth rate of 25.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 4.77B | -4.54% |
| Dec 31, 2025 | 5.00B | 48.76% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celcuity | 5.59B |
| Xenon Pharmaceuticals | 5.50B |
| Erasca | 5.30B |
| Caris Life Sciences | 5.30B |
| Apellis Pharmaceuticals | 5.20B |
| Immunovant | 5.01B |
| TG Therapeutics | 4.93B |
| Dianthus Therapeutics | 4.56B |